首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

European Journal Of Pharmaceutical Sciences

European Journal Of Pharmaceutical Sciences杂志,由Elsevier出版,于1993年创刊,Monthly,出版语言English,ISSN:0928-0987,E-ISSN:1879-0720。

投稿咨询
European Journal Of Pharmaceutical Sciences
European Journal Of Pharmaceutical Sciences
European Journal Of Pharmaceutical Sciences
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.1
CiteScore
8.6
期刊收录
SCI、SCIE

European Journal Of Pharmaceutical Sciences(中文译名:《欧洲药学杂志》),ISSN:0928-0987,EISSN:1879-0720,是Elsevier出版的国际性学术期刊,创刊于1993年,以Monthly形式稳定发行,2026年总发文量约362篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.1,2025年期刊CiteScore为8.6,2025年期刊自引率约5.9%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。European Journal Of Pharmaceutical Sciences长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约3.0个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、GERMANY (FED REP GER)、England、India、Brazil、Italy等为核心发文国家与地区;UNIVERSITY OF COPENHAGENSHENYANG PHARMACEUTICAL UNIVERSITY、CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)、CHINA PHARMACEUTICAL UNIVERSITY、UNIVERSITY OF LONDON、KU LEUVEN、NATIONAL & KAPODISTRIAN UNIVERSITY OF ATHENS等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 65 / 356

81.9

学科:PHARMACOLOGY & PHARMACY SCIE Q1 42 / 356

88.34

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 54 / 352

84.8

学科:PHARMACOLOGY & PHARMACY SCIE Q1 39 / 353

89.09


中国学者近期发文

1
Aerosolized adenoviral IL4/IL10 delivery alleviates LPS-induced acute lung injur

Author:Wang, Min; Zhang, Yaoyang; Hao, Yuxin; Zhu, Qinyao; He, Wei; Jia, Hui; Shan, Xiaojiao; Xun, Yue; Liu, Yifan; Liu, Yu; Zhang, Luo; Yin, Xiushan; Xia, Shuyue

Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 221, Issue , pp. -. DOI: 10.1016/j.ejps.2026.107512

2
FOSL1 mediates collagen synthesis and myofibroblast transformation in aortic fibroblasts under Ang II-induced aortic dissection condition

Author:Zhong, Lin; Zhang, Hui; Huang, Youqi; Zhang, Li; Zhang, Lin; Liu, Qin; Liao, Yuqing; Zhang, Qinghua; Fu, Wenjie; Wang, Chaoyun; Li, Xinyao; Chen, Liangwan; Li, Yumei

Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 221, Issue , pp. -. DOI: 10.1016/j.ejps.2026.107504

3
PET/CT imaging of the peptide-based anti-CD47 probe [18F]AlF-NOTA-Pep-20 in preclinical model

Author:Bao, Guangfa; Tang, Ming; Dong, Yajie; Li, Huiru; Wang, Shaobo

Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 221, Issue , pp. -. DOI: 10.1016/j.ejps.2026.107528

4
Chagasin-based carriers designed for the cancer-targeted release of protease

Author:Jai, Jyotsna; Liu, Yiling; Han, Xiao; Vong, Kenward

Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 221, Issue , pp. -. DOI: 10.1016/j.ejps.2026.107524

5
Targeting the xylosyltransferase TMEM5 in glioblastoma to modulate CLOCK and CRY1 expression and restore temozolomide sensitivity via the circadian signaling axi

Author:Su, Yu-Kai; Chuang, Hao-Yu; Liu, Heng-Wei; Yadav, Vijesh Kumar; Fong, Iat-Hang; Huang, Hui-Chuan; Lin, Chien-Min

Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 221, Issue , pp. -. DOI: 10.1016/j.ejps.2026.107497

6
Absorption, distribution, metabolism, excretion and mass balance of ainuovirine, a non-nucleoside reverse transcriptase inhibitor in human

Author:Wu, Yuechan; Ma, Sheng; Yun, Xinming; He, Fengying; Huang, Guancheng; Qin, Hong; Miao, Liyan; Zhang, Hua

Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 220, Issue , pp. -. DOI: 10.1016/j.ejps.2026.107471

7
Safety, pharmacokinetics, and pharmacodynamics of GS1-144, a neurokinin-3 receptor antagonist: A randomized phase 1 single and multiple ascending dose and food effect stud

Author:Wu, Xiaojie; Wang, Jingjing; Yang, Xinyi; Wang, Qianqian; Luo, Tianhong; Pan, Chao; Ma, Guangli; Zhu, Xiaoyan; Chen, Haijun; Shen, Hongshuang; Zhao, Tangping; Zhang, Jing

Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 220, Issue , pp. -. DOI: 10.1016/j.ejps.2026.107443

8
Preclinical evaluation of 89Zr/177Lu-labelled anti-B7-H3 monoclonal antibody for theranostics in B7-H3-positive liver cance

Author:Liang, Yuanyuan; Wu, Tao; Lu, Zhou; Yang, Xia; Du, Yang; Chen, Zhengguo; Luo, Rui; Shi, Mingsong; Li, Xiaoan; Zhou, Yan

Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 220, Issue , pp. -. DOI: 10.1016/j.ejps.2025.107371

9
Calpain inhibition preserves myofilament integrity and prevents vandetanib-induced cardiac dysfunctio

Author:Ji, Fang; Huang, Jie; Yan, Jie; Lv, Si; Lu, Lin; Wen, Hu; Lu, Jian; Yuan, Huan; Gu, Yinshan; Liao, Bin; Wu, Lin; Xie, Bingbin; Li, Miaoling

Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 220, Issue , pp. -. DOI: 10.1016/j.ejps.2026.107490

10
Glycyl-L-histidyl-L-lysine as a novel co-former in co-amorphous systems: Enhanced aqueous solubility and physical stabilit

Author:Huang, Qiang; Zou, Zhiren; Cheng, Dian; Gao, Ruyu; Zhou, Lin; Wu, Wencheng; Yuan, Yinyin; Chun, ChangJu; Huang, Yuye; Liang, Guang; Wu, Wenqi

Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 220, Issue , pp. -. DOI: 10.1016/j.ejps.2026.107493


在线咨询

European Journal Of Pharmaceutical Sciences

国际简称:EUR J PHARM SCI参考译名:欧洲药学杂志

年发文量:362 CiteScore:8.6 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:97.79%

杂志社联系方式:ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

European Journal Of Pharmaceutical Sciences